IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB:CORX) announced that Mark A. Varney, Ph.D., President and CEO, will speak at the 23rd Annual Roth Capital Partners Growth Stock Conference to be held at The Ritz-Carlton, Laguna Niguel hotel located in Dana Point, California. Dr. Varney will present on Wednesday, March 16, 2011, at 1:00 pm PST (4:00 pm EST). The conference will feature executives from over 400 growth companies across a broad spectrum of sectors, including energy, software, technology, healthcare, media and consumer products. Dr. Varney will provide an update on Cortex’s 2011 corporate objectives and milestones, including recent progress on its lead Ampakine® clinical compound, CX1739, as a novel drug therapy for sleep apnea and ADHD, along with other scientific and corporate developments. A live webcast of the presentation can be accessed by logging onto http://www.wsw.com/webcast/roth24/cor/. A replay will be available for thirty days following the conference. More information regarding the conference can be found at the link to the Roth conference website, http://www.roth.com/main/page.aspx?PageID=7236.
